References
- Lips P., Wiersinga A., Van Ginkel F. C., Jongen M. J. M., Netelenbos J. C., Hackeng W. H. L., et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988; 67: 644–50
- Chapuy M. C., Arlot M. E., Duboeuf F., Brun J., Crouzet B., Arnaud S., et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637–42
- Thomas M. K., Lloyd‐Jones D. M., Thadani R. I., Shaw A. C., Deraska D. J., Kitch B. T., et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777–83
- Mathieu C., Waer M., Laureys J., Rutgeerts O., Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25‐dihydroxycholecalciferol D3. Diabetologia 1994; 37: 552–8
- Patel S., Farragher T., Berry J., Bunn D., Silman A., Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007; 56: 2143–9
- Arnson Y., Amital H., Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137–42
- Holick M. F. Vitamin D: importance in the prevention of cancers, type I diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004; 79: 362–71
- Heaney R. P. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005; 97: 13–19
- DeLappe E., McGreevy C., Ni Chadhain N., Grimes H., O'Brien T., Mulkerrin E. Vitamin D insufficiency in older female community‐dwelling acute hospital admissions and the response to supplementation. Eur J Clin Nutr 2006; 60: 1009–15
- Cesur Y., Caksen H., Gundem A., Kirimi E., Odabas D. Comparison of low and high dose of vitamin D treatment in nutritional vitamin D deficiency rickets. J Pediatr Endocrinol Metab 2003; 16: 1105–9
- Heaney R. P., Davies K. M., Chen T. C., Holick M. F., Barger‐Lux M. J. Human serum 25‐hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77: 204–10
- Barger‐Lux M. J., Heaney R. P., Dowell S., Chen T. C., Holick M. F. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteopor Int 1998; 8: 222–30
- Vieth R. Vitamin D supplementation, 25‐hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842–56
- Vasquez A., Manso G., Cannell J. The clinical importance of vitamin D (cholecalciferol): a paradigm shift with implications for all healthcare providers. Altern Ther Health Med 2004; 10: 28–38
- Carter G. D., Carter R., Jones J., Berry J. How accurate are assays for 25‐hydroxyvitamin D? Data from the International Vitamin D External Quality Assessment Scheme. Clin Chem 2004; 50: 2195–7
- Hollis B. W. Comparison of commercially available 125I‐based RIA methods for the determination of circulating 25‐hydroxyvitamin D. Clin Chem 2000; 46: 1657–61
- Leventis P., Garrison L., Sibley M., Peterson P., Egerton M., Levin G., et al. Underestimation of serum 25‐hydroxyvitamin D by the Nichols Advantage assay in patients receiving vitamin D replacement therapy. Clin Chem 2005; 51: 1072–4
- Trang H., Cole D. E., Rubin L. A., Pierratos A., Siu S., Vieth R. Evidence that vitamin D3 increases serum 25‐hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998; 68: 854–8
- Armas L. A. G., Hollis B. W., Heaney R. P. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89: 5387–91
- Romagnoli E., Mascia M. L., Cipriani C., Fassino V., Mazzei F., D'Erasmo E., et al. Short‐ and long‐term variations in serum calciotrophic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrin Metab 2008; 93: 3015–20
- Dawson‐Hughes B., Heaney R. P., Holick M. F., Lips P., Meunier P. J., Vieth R. Estimates of optimal vitamin D status. Osteoporosis Int 2005; 16: 713–16